Evidence map›Paper›PMID 27340446›Full record

ArticleBeilstein journal of organic chemistry2016

New synthetic strategies for xanthene-dye-appended cyclodextrins.

Milo Malanga, Andras Darcsi, Mihaly Balint, Gabor Benkovics, Tamas Sohajda, Szabolcs Beni

Open access · diamondAbstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Novel β-cyclodextrin-eosin conjugates.Beilstein journal of organic chemistry · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Milo MalangaCycloLab, Cyclodextrin R&D Ltd., Budapest, H-1097 Illatos út 7, Hungary.
Andras DarcsiDepartment of Pharmacognosy, Semmelweis University, H-1085 Üllői út 26, Hungary.
Mihaly BalintCycloLab, Cyclodextrin R&D Ltd., Budapest, H-1097 Illatos út 7, Hungary.
Gabor BenkovicsCycloLab, Cyclodextrin R&D Ltd., Budapest, H-1097 Illatos út 7, Hungary; Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 12843 Prague 2, Czech Republic.
Tamas SohajdaCycloLab, Cyclodextrin R&D Ltd., Budapest, H-1097 Illatos út 7, Hungary.
Szabolcs BeniDepartment of Pharmacognosy, Semmelweis University, H-1085 Üllői út 26, Hungary.
CycloLab (Hungary) · HUSemmelweis University · HUCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xanthene dyes can be appended to cyclodextrins via an ester or amide bridge in order to switch the fluorescence on or off. This is made possible through the formation of nonfluorescent lactones or lactams as the fluorophore can reversibly cyclize. In this context we report a green approach for the synthesis of switchable xanthene-dye-appended cyclodextrins based on the coupling agent 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM). By using 6-monoamino-β-cyclodextrin and commercially available inexpensive dyes, we prepared rhodamine- and fluorescein-appended cyclodextrins. The compounds were characterized by NMR and IR spectroscopy and MS spectrometry, their UV-vis spectra were recorded at various pH, and their purity was determined by capillary electrophoresis. Two potential models for the supramolecular assembly of the xanthene-dye-appended cyclodextrins were developed based on the set of data collected by the extensive NMR characterization.

Indexed as

DMT-MMfluoresceinrhodaminesupramolecular assembly

Identifiers

PMID27340446
PMCPMC4902026
OpenAlexW2313887182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.